de Verneuil Vanina 4
4 · Vir Biotechnology, Inc. · Filed Dec 4, 2024
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP, General Counsel, Corp Sec
Transactions
- Sale
Common Stock
2024-12-02$8.22/sh−76$625→ 56,973 total
Footnotes (2)
- [F1]The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date.
- [F2]Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024.